Partially purified leaf extracts of Melia azedarach L. inhibit tacaribe virus growth in neonatal mice

Neonatal mice, inoculated intraperitoneally with 103 PFU of Tacaribe virus, died after developing a typical encephalitis. The administration of partially purified extracts of Melia azedarach L. (Ma) fresh green leaves, in seven doses by the same route, reduced virus spread which normally involves the kidneys, liver and brain. Mortality fell to 50% in treated mice and viral titres in brain were at least 3 logs lower than those of untreated mice. Surviving mice mounted a humoral immune response. High levels of neutralizing antibodies were present up to 60 days post‐infection when the animals were killed. Ma administration exerts a marked decrease in circulating interferon levels of infected mice. Thus, at day 6 post‐infection the amount of acid resistant interferon in treated animals was eight times lower than in those untreated.

[1]  M. Courreges,et al.  Meliacine, an antiviral compound from Melia azedarach L., inhibits interferon production. , 1990, Journal of interferon research.

[2]  J. Huggins,et al.  Ribavirin prophylaxis and therapy for experimental argentine hemorrhagic fever , 1988, Antimicrobial Agents and Chemotherapy.

[3]  J. McCormick,et al.  Therapeutic Effect of the Antiviral Agent Ribavirin in Junin Virus Infection of Primates , 1986, Journal of medical virology.

[4]  D. Woodrow,et al.  Antibody to mouse alpha/beta interferon abrogates Pichinde virus-induced liver lesions in suckling mice , 1986, Journal of virology.

[5]  M. Weissenbacher,et al.  Nasal and intrathalamic inoculations of primates with Tacaribe virus: protection against Argentine hemorrhagic fever and absence of neurovirulence. , 1984, Acta virologica.

[6]  P. Jahrling,et al.  Enhanced treatment of Lassa fever by immune plasma combined with ribavirin in cynomolgus monkeys. , 1984, The Journal of infectious diseases.

[7]  E. Damonte,et al.  Cross-protection in nonhuman primates against Argentine hemorrhagic fever , 1982, Infection and immunity.

[8]  R. Wannemacher,et al.  Plasma disappearance, urine excretion, and tissue distribution of ribavirin in rats and rhesus monkeys , 1981, Antimicrobial Agents and Chemotherapy.

[9]  P. Jahrling,et al.  Lassa virus infection of rhesus monkeys: pathogenesis and treatment with ribavirin. , 1980, The Journal of infectious diseases.

[10]  J. Gresser,et al.  Anti-interferon globulin inhibits the development of glomerulonephritis in mice infected at birth with lymphocytic choriomeningitis virus. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[11]  I. Gresser,et al.  Inhibition by anti-interferon serum of lymphocytic choriomeningitis virus disease in suckling mice. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[12]  E. Borden,et al.  Tacaribe virus infection of the mouse: an immunopathologic disease model. , 1974, Laboratory investigation; a journal of technical methods and pathology.

[13]  T. Monath,et al.  Effect of Antilymphocyte Serium on Tacaribe Virus Infection in Infant Mice , 1971, Infection and Immunity.

[14]  C. Coto,et al.  Argentine hemorrhagic fever. , 1987, Current topics in microbiology and immunology.

[15]  A. Valsamakis,et al.  Arenaviruses , 1987, Current Topics in Microbiology and Immunology.

[16]  E. Damonte,et al.  [Immunization of guinea pigs against Argentinian hemorrhagic fever with Tacaribe virus replicated in human diploid cells]. , 1981, Medicina.

[17]  A. Teyssié,et al.  [Interferon induction by Tacaribe virus]. , 1981, Medicina.